Standout Papers

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immu... 2016 2026 2019 2022 1.1k
  1. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy (2017)
    Antoni Ribas, Reinhard Dummer et al. Cell
  2. Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma (2017)
    Jason Chesney, Igor Puzanov et al. Journal of Clinical Oncology
  3. Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma (2016)
    Igor Puzanov, Mohammed Milhem et al. Journal of Clinical Oncology
  4. Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas (2021)
    Funda Meric‐Bernstam, Randy F. Sweis et al. Clinical Cancer Research

Immediate Impact

3 by Nobel laureates 19 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Understanding tumour endothelial cell heterogeneity and function from single-cell omics
2023 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout

Works of Robert H.I. Andtbacka being referenced

Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma
2022
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
2017 Standout

Author Peers

Author Last Decade Papers Cites
Robert H.I. Andtbacka 3352 1710 1584 1774 91 5.2k
Christina Addison 2479 2102 967 1538 89 5.1k
Albert Deisseroth 2364 2617 933 993 139 5.6k
Paul K. Pattengale 2124 2460 1277 1485 56 5.7k
HP Koeffler 1771 3065 821 1639 90 6.5k
George Morstyn 2554 1098 1199 1039 109 5.6k
Kimberly R. Kalli 2012 2125 568 1620 100 5.3k
Matthew L. Sherman 2106 3184 697 2204 132 7.7k
François Martin 3819 1547 1321 4133 71 7.7k
Yoshito Ueyama 2536 3161 681 1290 197 6.5k
Jing Sun 3691 2077 542 4861 118 7.9k

All Works

Loading papers...

Rankless by CCL
2026